Organon & Samsung Bioepis Launch HADLIMA™ Biosimilar of HUMIRA in the US

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” ...

July 03, 2023 | Monday | News
Bionano Announces the Stratys™ System for OGM and VIA™ Software for Hematologic Malignancies

The Stratys™ instrument for optical genome mapping (OGM) will enable a four-fold increase in raw data generation rate compared to the Saphyr® i...

June 30, 2023 | Friday | News
Thermo Fisher Scientific Launches Cancer Treatment-Enabling Tumor Culture Medium

Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...

June 29, 2023 | Thursday | News
Theriva Biologics Receives FDA Orphan Drug Designation for VCN-01 in Pancreatic Cancer Treatment

In VIRAGE, the ongoing multinational Phase 2b clinical study, intravenous VCN-01 is being evaluated in combination with standard-of-care (SoC) chemotherapy...

June 28, 2023 | Wednesday | News
Antibody-Drug Conjugates Clinical Trial Pipeline Gains Momentum with 180+ Companies: DelveInsight.

DelveInsight's 'Antibody-drug Conjugates Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...

June 27, 2023 | Tuesday | News
Twist Bioscience Publishes Preclinical Data Validating GLP-1R Antagonist Antibody for Congenital Hyperinsulinism Treatment.

-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

June 27, 2023 | Tuesday | News
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics

Merger approved with large majority by the shareholders of both companies New governance structure implemented Ambition to create a global leader in ex...

June 27, 2023 | Tuesday | News
Challenges and strategies for characterization of next-generation bispecific antibodies

But developing a bispecific antibody presents several challenges, including those related to dual binding, screening, pharmacodynamics, tissue tropism, and...

June 22, 2023 | Thursday | Analysis
FBI Approves QIAGEN's ForenSeq MainstAY Workflow for U.S. DNA Index System

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that the U.S. Federal Bureau of Investigation (FBI) has approved its ForenSeq® Mains...

June 22, 2023 | Thursday | News
Next-gen Cologuard test raises non-invasive screening bar with 94% sensitivity for colorectal cancer at 91% specificity.

BLUE-C study met all endpoints, showing improved cancer sensitivity, specificity, and precancer sensitivity 20,000-participant study reflects racial ...

June 21, 2023 | Wednesday | News
Illumina Ventures to Launch Illumina® Ventures Labs

“This expansion of our relationship with Illumina is a continuation of Illumina Ventures’ strategy to pursue earlier stage investing,” sa...

June 21, 2023 | Wednesday | News
Abu Dhabi, M42, AbbVie Partner to Advance Personalized Medicine & Genomics

The MoU was signed by Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Center at the Department of Health – Abu Dhabi(DoH), Fra...

June 20, 2023 | Tuesday | News
TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody

TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the F...

June 17, 2023 | Saturday | News
Promising Results in Early-Stage Study of Hodgkin Lymphoma with Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy

Safety data encouraging with no graft-versus-host-disease and no neurotoxicity Updated data highlighted in podium presentation at the 17th International...

June 16, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close